Far-Red Light Activatable, Multifunctional Prodrug for Fluorescence Optical Imaging and Combinational Treatment

We recently developed “photo-unclick chemistry”, a novel chemical tool involving the cleavage of aminoacrylate by singlet oxygen, and demonstrated its application to visible light-activatable prodrugs. In this study, we prepared an advanced multifunctional prodrug, Pc-(L-CA4)2, composed of the fluorescent photosensitizer phthalocyanine (Pc), an SO-labile aminoacrylate linker (L), and a cytotoxic drug combretastatin A-4 (CA4). Pc-(L-CA4)2 had reduced dark toxicity compared with CA4. However, once illuminated, it showed improved toxicity similar to CA4 and displayed bystander effects in vitro. We monitored the time-dependent distribution of Pc-(L-CA4)2 using optical imaging with live mice. We also effectively ablated tumors by the illumination with far-red light to the mice, presumably through the combined effects of photodynamic therapy (PDT) and released chemotherapy drug, without any sign of acute systemic toxicity.

[1]  R. Breslow,et al.  A cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. van den Bergh,et al.  Like a Bolt from the Blue: Phthalocyanines in Biomedical Optics , 2011, Molecules.

[3]  Michael S Patterson,et al.  Direct Near-infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo¶ , 2002, Photochemistry and photobiology.

[4]  Tymish Y. Ohulchanskyy,et al.  Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives. , 2003, Journal of medicinal chemistry.

[5]  J. Grembecka,et al.  Structure-based discovery of a boronic acid bioisostere of combretastatin A-4. , 2005, Chemistry & biology.

[6]  N. Lawrence,et al.  Novel syntheses of cis and trans isomers of combretastatin A-4. , 2001, The Journal of organic chemistry.

[7]  G. Ghosh,et al.  A Hand‐held Fiber‐optic Implement for the Site‐specific Delivery of Photosensitizer and Singlet Oxygen , 2011, Photochemistry and photobiology.

[8]  W. Fong,et al.  Phthalocyanine-polyamine conjugates as highly efficient photosensitizers for photodynamic therapy. , 2011, Journal of medicinal chemistry.

[9]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[10]  J. Lambert,et al.  Lifetime and diffusion of singlet oxygen in a cell. , 2005, The journal of physical chemistry. B.

[11]  Samuel G. Awuah,et al.  Site-specific and far-red-light-activatable prodrug of combretastatin A-4 using photo-unclick chemistry. , 2013, Journal of medicinal chemistry.

[12]  G. Ghosh,et al.  Photosensitizer drug delivery via an optical fiber. , 2011, Journal of the American Chemical Society.

[13]  Samuel G. Awuah,et al.  Visible Light Controlled Release of Anticancer Drug through Double Activation of Prodrug. , 2013, ACS medicinal chemistry letters.

[14]  Moses Bio,et al.  Low energy light-triggered oxidative cleavage of olefins , 2009 .

[15]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Won Jong Kim,et al.  Mesoporous silica nanoparticle facilitated drug release through cascade photosensitizer activation and cleavage of singlet oxygen sensitive linker. , 2013, Chemical communications.

[17]  Moses Bio,et al.  Click and photo-unclick chemistry of aminoacrylate for visible light-triggered drug release. , 2012, Chemical communications.

[18]  J. Moan,et al.  On the diffusion length of singlet oxygen in cells and tissues , 1990 .

[19]  D. Dolphin,et al.  Site-specific prodrug release using visible light. , 2008, Journal of the American Chemical Society.

[20]  Youngjae You,et al.  Emerging Strategies for Controlling Drug Release by Using Visible/Near IR Light , 2013 .

[21]  Tristan Barrett,et al.  Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes , 2009, Nature Medicine.

[22]  N. Oleinick,et al.  The Synthesis, Photophysical and Photobiological Properties and in vitro Structure‐Activity Relationships of a Set of Silicon Phthalocyanine PDT Photosensitizers , 1997, Photochemistry and photobiology.

[23]  M. E. Kenney,et al.  Structural Factors and Mechanisms Underlying the Improved Photodynamic Cell Killing with Silicon Phthalocyanine Photosensitizers Directed to Lysosomes Versus Mitochondria , 2009, Photochemistry and photobiology.

[24]  P. Qi,et al.  3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking , 2011, Molecules.

[25]  W. Fong,et al.  A pH-responsive fluorescence probe and photosensitiser based on a tetraamino silicon(IV) phthalocyanine. , 2010, Chemical communications.

[26]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[27]  Carmen Alvarez-Lorenzo,et al.  Light‐sensitive Intelligent Drug Delivery Systems † , 2009, Photochemistry and photobiology.

[28]  Tae-You Kim,et al.  Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies , 2004, Clinical Cancer Research.

[29]  P. Ang,et al.  Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.